Corrigendum: Endothelin-A Receptor Antagonist Alleviates Allergic Airway Inflammation via the Inhibition of ILC2 Function

Front Immunol. 2022 Mar 28:13:877694. doi: 10.3389/fimmu.2022.877694. eCollection 2022.

Xiaogang Zhang¹, Ziyang Chen², Shaowen Zuo¹, Hengbiao Sun³, Xinyao Li¹, Xiao Lu¹, Zhe Xing¹, Meiqi Chen¹, Jingping Liu³, Gang Xiao³, Yumei He^{1

4

5}

¹ Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
² Department of Neurosurgery Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
³ Department of Clinical Laboratory, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China.
⁴ Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Southern Medical University, Guangzhou, China.
⁵ Guangdong Provincial Key Laboratory of Proteomics, Southern Medical University, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.835953.].

Keywords: BQ123; allergic airway inflammation; endothelin-A receptor antagonist; group 2 innate lymphoid cell; therapeutic.